As of the latest Form 4 filed Jul 2, 2026.
What Royalty Pharma Plc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 23 most recent filings for RPRX.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-02 | 2026-07-01 | Urist Marshall EVP, Research & Investments | SSale | −9.10K | $55.88 | $508K | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Hite Christopher EVP & Chairman, Partnering | SSale | −600.00 | $57.09 | $34.3K | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Hite Christopher, EVP & Chairman, Partnering | SSale | −29.4K | $56.44 | $1.66M | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Hite Christopher, EVP & Chairman, Partnering | SSale | −2.55K | $57.10 | $146K | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Hite Christopher, EVP & Chairman, Partnering | SSale | −97.4K | $56.50 | $5.51M | Yes (planned) | Form 4 ↗ |
| 2026-06-30 | 2026-06-30 | Bassler Bonnie L Director | AAward | +689.00 | $54.40 | $37.5K | No | Form 4 ↗ |
| 2026-06-25 | 2026-06-24 | Urist Marshall EVP, Research & Investments | SSale | −9.10K | $55.18 | $502K | Yes (planned) | Form 4 ↗ |
| 2026-06-25 | 2026-06-23 | Hite Christopher EVP & Chairman, Partnering | SSale | −118K | $54.47 | $6.41M | Yes (planned) | Form 4 ↗ |
| 2026-06-25 | 2026-06-23 | Hite Christopher, EVP & Chairman, Partnering | SSale | −32.4K | $54.11 | $1.75M | Yes (planned) | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | Engelbert Catherine M. Director | AAward | +4.54K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | Ho Carole Director | AAward | +4.54K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | Coric Vlad Director | AAward | +4.54K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | Bassler Bonnie L Director | AAward | +4.54K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | Norden Gregory Director | AAward | +4.54K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | HODGSON DAVID C Director | AAward | +4.54K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | LOVE TED W Director | AAward | +4.54K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | WEATHERMAN ELIZABETH H Director | AAward | +4.54K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Coyne Terrance P. EVP & CFO | SSale | −64.4K | $53.98 | $3.48M | Yes (planned) | Form 4 ↗ |
| 2026-04-30 | 2026-04-28 | Coyne Terrance P. EVP & CFO | SSale | −1.88K | $49.78 | $93.3K | Yes (planned) | Form 4 ↗ |
| 2026-04-30 | 2026-04-28 | Coyne Terrance P., EVP & CFO | SSale | −32.9K | $49.78 | $1.64M | Yes (planned) | Form 4 ↗ |
| 2026-03-31 | 2026-03-31 | Bassler Bonnie L Director | AAward | +815.00 | $45.98 | $37.5K | No | Form 4 ↗ |
| 2026-03-25 | 2026-03-23 | Coyne Terrance P. EVP & CFO | SSale | −1.88K | $45.53 | $85.4K | Yes (planned) | Form 4 ↗ |
| 2026-03-25 | 2026-03-23 | Coyne Terrance P., EVP & CFO | SSale | −32.9K | $45.53 | $1.50M | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also RPRX’s full analysis or the market-wide insider trading feed. The tabs above jump to RPRX’s other SEC data.
Source: SEC Form 4 filings for RPRX, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.